ARCT-032
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Arcturus Therapeutics, Inc.
Overview
ARCT-032 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ARCT-032 clinical trials
Explore related
Medical disclaimer. This page summarizes research about ARCT-032 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.